ADC Therapeutics SA
ADCT----
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a C...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
ADC Therapeutics SA Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$5.00311.52%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy0.00%
- Hold40.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 2 days ago, 02:52 PM
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
- Tip Ranks · Jul 8 at 08:46 PM
RBC Capital Keeps Their Hold Rating on ADC Therapeutics (ADCT)
- Tip Ranks · Jul 2 at 04:30 PM
ADC Therapeutics Grants One-Time Retention Awards to Executives
- TradingView · Jul 2 at 04:13 PM
ADC awards retention incentives to CEO Ameet Mallik, CFO Jose Carmona and CMO Mohamed Zaki
- PUBT · Jul 1 at 03:07 PM
ADC Therapeutics grants new employee options for 17,000 shares under inducement plan
- Unusual Whales · Jul 1 at 03:06 PM
ADC Therapeutics Announces New Employee Inducement Grant
